말 인공수정 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 솔루션별, 말 유형별, 유통 채널별, 지역별, 경쟁 시장별(2020-2030년)

Equine Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution, By Equine Type, By Distribution Channel, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,240,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,627,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,094,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계 말 인공수정 시장은 2024년 6억 5,806만 달러로 평가되었고, 2030년에는 9억 2,324만 달러에 달할 것으로 예상되며, 5.78%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

이 시장은 생식 기술의 발전과 유전적으로 우수한 말 품종에 대한 수요 증가로 인해 크게 성장하고 있습니다. 말 산업에서 인공수정(AI)의 채택이 증가하고 있으며, 번식업자들은 유전적 다양성을 높이고 질병 전파의 위험을 줄일 수 있게 되었습니다. 경주, 장애물, 마장마술과 같은 승마 경기의 인기가 높아짐에 따라 고성능 말 수요가 더욱 증가하여 보조생식기술의 활용을 촉진하고 있습니다. 업계 리더들은 수태율을 높이기 위해 정액 보존 기술 향상과 인공수정 방법의 혁신에 주력하고 있으며, 그 결과 번식 목장과 동물병원 전체에서 AI가 널리 채택되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	6억 5,806만 달러
시장 규모 : 2030년	9억 2,324만 달러
CAGR : 2025-2030년	5.78%
급성장 부문	프라이빗
최대 시장	북미

주요 시장 성장 촉진요인

말의 유전적 개량

주요 시장 과제

규제 대응: 복잡한 상황

주요 시장 동향 :

유전체 검사를 통한 고정밀 유전자 선택

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 말 인공수정 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 솔루션별(기기 및 소모품, 정액(일반 정액, 성별 판별 정액), 서비스)
  • 말 유형별(스포츠 및 경마, 레크리에이션, 기타)
  • 유통 채널별(민간, 공공)
  • 지역별
  • 기업별(2024년)
• 제품 시장 맵
  • 솔루션별
  • 말 유형별
  • 유통 채널별
  • 지역별

제6장 북미의 말 인공수정 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 말 인공수정 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 말 인공수정 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 말 인공수정 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 말 인공수정 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 인수합병(M&A)
• 제품 출시

제13장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• IMV Technologies SADIR
• Stallion A I Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc S.r.o.
• CVS UK Ltd
• HOFFMAN A.I. BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH

영문 목차

영문목차

Global Equine Artificial Insemination Market was valued at USD 658.06 million in 2024 and is projected to reach USD 923.24 million by 2030, growing at a compound annual growth rate (CAGR) of 5.78%. This market is experiencing substantial expansion, driven by advancements in reproductive technologies and a growing demand for genetically superior horse breeds. The increasing adoption of artificial insemination (AI) within the equine industry has enabled breeders to enhance genetic diversity and mitigate the risk of disease transmission. The rising popularity of equestrian sports, such as racing, show jumping, and dressage, is further fueling the demand for high-performance horses, thus encouraging the use of assisted reproductive technologies. Industry leaders are focusing on improving semen preservation techniques and innovating insemination methods to enhance fertility rates, resulting in broader adoption of AI across breeding farms and veterinary clinics.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 658.06 Million
Market Size 2030	USD 923.24 Million
CAGR 2025-2030	5.78%
Fastest Growing Segment	Private
Largest Market	North America

Key Market Drivers:

Genetic Improvement in Equine Traits

The equine breeding industry is undergoing a significant shift, driven by the pursuit of superior genetic traits in horses. This quest for genetic excellence has accelerated the growth of the Global Equine Artificial Insemination (AI) Market as breeders increasingly rely on advanced reproductive technologies to improve and refine the genetic composition of their horses. Artificial insemination offers several advantages over traditional mating methods, including access to genetic material from top sires worldwide, which breaks geographical barriers and diversifies the gene pool. This technology allows breeders to selectively pair stallions with desirable traits-such as speed, endurance, agility, and temperament-to produce offspring suited for various disciplines like racing, show jumping, dressage, and workhorse functions.

Additionally, AI helps preserve genetic diversity within equine populations, minimizing the risks associated with inbreeding by introducing fresh genetic material. The technology also accelerates genetic progress by enabling the production of multiple offspring from a single stallion in one breeding season, thus enhancing the breed's overall quality and performance. The demand for high-quality, genetically superior horses is rising, fueled by competitive sports, leisure riding, and other equine-related activities. As breeders aim to meet these market demands, artificial insemination has become a vital tool in achieving their goals. For instance, the equine industry in the United Kingdom plays a significant role in the economy, with substantial spending on breeding, training, and recreational activities. The Department for Environment, Food & Rural Affairs (DEFRA) regulates equine semen collection and storage, ensuring compliance with rigorous standards to safeguard the health and quality of the equine population.

Key Market Challenges:

Regulatory Compliance: A Complex Landscape

A primary challenge in the equine artificial insemination market is navigating the complex and varied regulatory landscape across different countries and regions. Each jurisdiction has its own set of rules governing equine breeding practices, including the use of artificial insemination. Ensuring compliance with these regulations can be a challenging task, particularly for breeders engaged in international trade. Understanding and adhering to these regulatory requirements is crucial to ensuring the legality and acceptance of artificially inseminated horses in various markets.

Key Market Trends:

Precision Genetic Selection through Genomic Testing

The trend toward precision breeding is gaining traction within the equine industry. Genomic testing, which analyzes an individual horse's DNA to assess its genetic potential, is becoming more accessible and cost-effective. This technology allows breeders to make informed decisions about stallion and mare pairings, optimizing the likelihood of producing offspring with desirable traits. As genomic testing becomes more widely adopted, it is expected to lead to even more selective breeding practices, fostering the creation of superior equine bloodlines.

Key Market Players

• IMV Technologies SADIR
• Stallion A I Services Ltd
• Zoetis Inc
• Neogen Corp
• Zerlotti Genetics Ltd
• Erc S.r.o.
• CVS UK Ltd
• HOFFMAN A.I. BREEDERS INC.
• Continental Genetics, LLC
• Minitub GmbH

Report Scope:

In this report, the Global Equine Artificial Insemination Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Equine Artificial Insemination Market, By Solution:

• Equipment & Consumables
• Semen
  • Normal Semen
  • Sexed Semen
• Services

Equine Artificial Insemination Market, By Equine Type:

• Sports/Racing
• Recreation
• Others

Equine Artificial Insemination Market, By Distribution Channel:

• Private
• Public

Equine Artificial Insemination Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Equine Artificial Insemination Market.

Available Customizations:

Global Equine Artificial Insemination market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Equine Artificial Insemination Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 5.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 5.2.3. By Distribution Channel (Private, Public)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Solution
  • 5.3.2. By Equine Type
  • 5.3.3. By Distribution Channel
  • 5.3.4. By Region

6. North America Equine Artificial Insemination Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 6.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 6.2.3. By Distribution Channel (Private, Public)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Equine Artificial Insemination Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Solution
      • 6.3.1.2.2. By Equine Type
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Equine Artificial Insemination Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Solution
      • 6.3.2.2.2. By Equine Type
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Equine Artificial Insemination Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Solution
      • 6.3.3.2.2. By Equine Type
      • 6.3.3.2.3. By Distribution Channel

7. Europe Equine Artificial Insemination Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 7.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 7.2.3. By Distribution Channel (Private, Public)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Equine Artificial Insemination Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Solution
      • 7.3.1.2.2. By Equine Type
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. United Kingdom Equine Artificial Insemination Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Solution
      • 7.3.2.2.2. By Equine Type
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. France Equine Artificial Insemination Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Solution
      • 7.3.3.2.2. By Equine Type
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Equine Artificial Insemination Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Solution
      • 7.3.4.2.2. By Equine Type
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Equine Artificial Insemination Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Solution
      • 7.3.5.2.2. By Equine Type
      • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Equine Artificial Insemination Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 8.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 8.2.3. By Distribution Channel (Private, Public)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Equine Artificial Insemination Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Solution
      • 8.3.1.2.2. By Equine Type
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Japan Equine Artificial Insemination Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Solution
      • 8.3.2.2.2. By Equine Type
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. India Equine Artificial Insemination Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Solution
      • 8.3.3.2.2. By Equine Type
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. Australia Equine Artificial Insemination Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Solution
      • 8.3.4.2.2. By Equine Type
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. South Korea Equine Artificial Insemination Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Solution
      • 8.3.5.2.2. By Equine Type
      • 8.3.5.2.3. By Distribution Channel

9. South America Equine Artificial Insemination Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 9.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 9.2.3. By Distribution Channel (Private, Public)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Equine Artificial Insemination Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Solution
      • 9.3.1.2.2. By Equine Type
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Argentina Equine Artificial Insemination Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Solution
      • 9.3.2.2.2. By Equine Type
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. Colombia Equine Artificial Insemination Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Solution
      • 9.3.3.2.2. By Equine Type
      • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Equine Artificial Insemination Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Solution (Equipment & Consumables, Semen (Normal Semen, Sexed Semen), Services)
  • 10.2.2. By Equine Type (Sports/Racing, Recreation, Others)
  • 10.2.3. By Distribution Channel (Private, Public)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Equine Artificial Insemination Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Solution
      • 10.3.1.2.2. By Equine Type
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Saudi Arabia Equine Artificial Insemination Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Solution
      • 10.3.2.2.2. By Equine Type
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. UAE Equine Artificial Insemination Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Solution
      • 10.3.3.2.2. By Equine Type
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. IMV Technologies SADIR
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Stallion A I Services Ltd
• 14.3. Zoetis Inc
• 14.4. Neogen Corp
• 14.5. Zerlotti Genetics Ltd
• 14.6. Erc S.r.o.
• 14.7. CVS UK Ltd
• 14.8. HOFFMAN A.I. BREEDERS INC.
• 14.9. Continental Genetics, LLC
• 14.10. Minitub GmbH

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료